Clinical and preclinical studies demonstrate GLP1 RAs as excellent weight loss drugs with therapeutic potential for obesityrelated illness, emphasizing the need for rigorous investigation to ensure safe clinical use in breast oncology
K., & Susser, L
doi: 10.1016/j.molmet.2021.101181 109 WillardFSDourosJDGabeMBShowalterADWainscottDBSuterTMet al
There is no hiding the rise of medically supervised weight-loss medications
Summary Keywords molecular screening, bilirubin, favism, hemolytic anemia, neonatal jaundice, peroxiredoxin 2, Heinz bodies, G6PD Citation Lee HY, Ithnin A, Azma RZ, Othman A, Salvador A and Cheah FC (2022) Glucose-6-Phosphate Dehydrogenase Deficiency and Neonatal Hyperbilirubinemia: Insights on Pathophysiology, Diagnosis, and Gene Variants in Disease Heterogeneity
If youre using it right, that is